Health Condition 1: B354- Tinea corporis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: consenting adults who are clinically diagnosed as tinea corporis
Exclusion criteria
Exclusion criteria: a. Patient with superficial dermatophytosis other than tinea corporis. b. Extensive tinea corporis more than 20% BSA c. Patients already on oral/topical antifungals. d. Pregnant and lactating mothers e. Patients on any immunosuppressant drugs/immunosuppressive patients f. Any Seropositive patient HIV, HbsAg , HCV , VDRL g. Patient with history of severe allergy or anaphylaxis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| . Whitfields ointment with Topical Luliconazole has better efficacy and better response time as compared to topical luliconazole in treatment of tinea corporisTimepoint: both modalities being compared at baseline , 14 days , 28 days. | — |
Secondary
| Measure | Time frame |
|---|---|
| The disease regression is faster in whitfields ointment with Topical Luliconazole as compared to topical luliconazole.Timepoint: baseline 14 days & 28 days | — |
Countries
India
Contacts
kalinga institute of medical sciences